⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
GLP-1 'Arms Race' Intensifies as the Addressable Markets Continue to Expand
accessnewswire.com
LEXX
NVO
LLY
Digital Champions CEE 2026: Celková hodnota se blíží 128 miliardám dolarů; region proměňují deeptech firmy a přesuny sídel společností
prnewswire.com
GOOG
MSFT
AMZN
NVDA
META
IBM
INTC
AMD
AVGO
CRM
CSCO
ADBE
ORCL
NFLX
CMCSA
DIS
BA
GD
LMT
RTX
HON
GE
CAT
DE
MMM
PG
JNJ
PFE
MRK
ABBV
BMY
GILD
AMGN
LLY
VRTX
REGN
BIIB
ALGN
ISRG
TDOC
EXPE
BKNG
AAPL
TSLA
GM
F
RIVN
LCID
NIO
XPEV
LI
PLTR
SNOW
CRWD
DDOG
PANW
MDB
PYPL
COIN
UPST
SOFI
HOOD
CRSP
EDIT
NTLA
BNTX
MRNA
NVAX
XOM
CVX
SHEL
T
VZ
TMUS
QCOM
MU
WDC
SE
BABA
JD
PDD
BIDU
NTES
GOOGL
America's Most Talked-About Drug Has a Surprising Secret: 69% of GLP-1 Users Are Unlikely to Admit Taking It
businesswire.com
LLY
4E Therapeutics Acquired by Lilly to Advance Non-Opioid Approach to Chronic Pain
prnewswire.com
LLY
Collibra Named Databricks' Governance Partner of the Year; Collibra and Databricks Deepening a Partnership to Ground Agentic AI in Governed Context
prnewswire.com
RIVN
MA
BABA
UBER
CMG
ADI
AMZN
GOOG
MSFT
NVDA
CRM
PYPL
IBM
INTC
ADBE
NFLX
HON
GE
BA
CAT
UNH
PEP
KO
MCD
COST
WMT
TMO
ABBV
XOM
CVX
JPM
BAC
WFC
C
GS
MS
DIS
CMCSA
VZ
T
SBUX
NKE
MDT
AMGN
GILD
BMY
PFE
MRK
JNJ
PG
LMT
RTX
GD
LRCX
MU
AMD
QCOM
TXN
AVGO
AMAT
KLAC
ASML
ENPH
CRSP
REGN
VRTX
BIIB
AZN
SNY
LLY
BNTX
XCUR
ALGN
TDOC
ZBRA
ROKU
UL
Liberty All-Star® Growth Fund, Inc. May 2026 Monthly Update
businesswire.com
NVDA
AAPL
GOOGL
MSFT
AMZN
MPWR
NVT
STRL
CDTX
CW
HGV
DDOG
LLY
META
TPR
Process Industries Converge in Houston for Inaugural ChemE Show 2026 Powered by ACHEMA
prnewswire.com
XOM
JNJ
LLY
LIN
FRO
APD
ETR
AA
PH
Rznomics Presents Clinical Interim Data for RZ-001 in Recurrent Glioblastoma at ASNO 2026
prnewswire.com
LLY
Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited regimen in people with previously treated CLL/SLL
prnewswire.com
LLY
Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting
prnewswire.com
LLY